Investor Alert

Denali Therapeutics Inc.



After Hours

 --Quotes are delayed by 20 min

Mar 21, 2023, 6:26 p.m.





+0.14 +0.60%


Volume 44,267

Quotes are delayed by 20 min


Today's close

$ 23.33

$ 23.26


-0.07 -0.30%

Day low

Day high




52 week low

52 week high




Nancy A. Thornberry

Currently, Nancy A. Thornberry holds the position of Advisor at GV Management Co. LLC. Ms. Thornberry is also on the board of 5 other companies.

In her past career she held the position of Senior VP, Head-Diabetes & Endocrinology at Merck & Co., Inc. and Principal at Merck Research Laboratories Massachusetts LLC (a subsidiary of Merck & Co., Inc.).

Nancy A. Thornberry received an undergraduate degree from Muhlenberg College.


Date Shares Transaction Value
06/02/2022 5,986   Award at $0 per share. 0
01/08/2022 627   Award at $0 per share. 0

Officers and Executives

Dr. Ryan J. Watts
President, Chief Executive Officer & Director
Dr. Alexander O. Schuth
Secretary, Chief Operating & Financial Officer
Dr. Joe Lewcock
Chief Scientific Officer
Dr. Carole Ho
Chief Medical Officer & Head-Development
Dr. Dana Andersen
CTO & Chief Manufacturing Officer
Ms. Katie Peng
Chief Commercial Officer
Mr. Steve E. Krognes
Dr. Laura G. Hansen
Vice President-Investor Relations
Ms. Cindy Dunkle
Chief People Officer
Dr. Chris Walsh
Associate General Counsel
Ms. Erica Kratz
Vice President-Regulatory
Dr. Vicki L. Sato
Non-Executive Chairman
Ms. Nancy A. Thornberry
Independent Director
Mr. Erik C. Harris
Independent Director
Dr. Marc Tessier-Lavigne
Independent Director
Dr. Douglas G. Cole
Independent Director
Mr. Jay T. Flatley
Independent Director
Dr. David Paul Schenkein
Independent Director
Mr. Peter S. Klein
Independent Director
Ms. Jennifer E. Cook
Independent Director
Link to MarketWatch's Slice.